Danish drugmaker Novo Nordisk is preparing to introduce its blockbuster drug Ozempic (semaglutide) in India, a move expected to benefit millions of patients with Type 2 diabetes. The development was confirmed by the company’s India Head, Vikrant Shro... [2850 chars].. reed more
